We are thrilled to announce that Chugai Pharma Germany GmbH will partner at Frontiers Health 2022!
With a pioneering spirit, Chugai Pharmaceutical Co., Ltd., headquartered in Tokyo, is a research-based pharmaceutical company with world-class drug discovery capabilities, including proprietary antibody engineering technologies. Chugai is committed to creating innovative pharmaceutical products that may satisfy unmet medical needs in the strategic fields of Immunology/Rheumatology, Haematology/Haemophilia, Oncology as well as other therapeutic areas that need serious advancements to keep pace with medical demands.
Chugai is listed on the Prime Market of the Tokyo Stock Exchange. While maintaining autonomy and management independence, Chugai is an important member of the Roche Group.
Dedicated to adding value by creating and delivering innovative products and services for the medical community and human health around the world, they will bring their unique innovative energy to further enrich the Frontiers Health ecosystem.